BioAtla, Inc. (BCAB) Q2 2024 Earnings
BCAB·Reported August 8, 2024·After market close
Diluted EPS came in at $-0.44, beat the $-0.45 consensus by $0.01.
Diluted EPS
$-0.44beat by $0.01
Consensus: $-0.45
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q2 2024 Earnings FAQ
Common questions about BioAtla, Inc.'s Q2 2024 earnings report.
BioAtla, Inc. (BCAB) reported Q2 2024 earnings on August 8, 2024 after market close.
BioAtla, Inc. reported diluted EPS of $-0.44 for Q2 2024.
EPS beat the consensus estimate of $-0.45 by $0.01.